ThermoGenesis Corp (NASDAQ:KOOL) will release the first quarter earnings for 2009 on Thursday, November 6. A conference call will be held that afternoon at 5:00 pm ET to discuss the financial results. The call may be heard by dialing 1-800-860-2442 or 1-412-858-4600 for international callers. Please reference “ThermoGenesis” when calling.
Speaking during the call is ThermoGenesis Chief Executive Officer Dr. William Osgood and Chief Financial Officer Matthew Plavan. A question and answer session will follow their presentation. Callers are encouraged to call five minutes prior to the start of the scheduled call.
ThermoGenesis Corp. designs, manufactures and markets automated and semi-automated devices and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells, wound healing proteins or growth factors from a single unit of cord blood or the patient’s own blood in less than one hour.
In February 2008, the Company announced the formation of a wholly owned subsidiary, Vantus Veterinary Stem Cell Laboratories (Vantus). Vantus involves a formal relationship with the
Read more Business News on The Global Market Directory.
About The Global Market Directory (TheGMD)
TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.
The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.
Create your profile on The Global Market Directory